Skip to main content
Top
Published in: Clinical Rheumatology 4/2011

01-04-2011 | Original Article

Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years

Authors: Fereydoun Davatchi, Farhad Shahram, Hormoz Shams, Abdolhadi Nadji, Cheyda Chams-Davatchi, Massoomeh Akhlaghi, Seyedeh Tahereh Faezi, Farima Ashofteh, Bahar Sadeghi-Abdollahi

Published in: Clinical Rheumatology | Issue 4/2011

Login to get access

Abstract

It is of general belief that males are prone to more frequent, more severe manifestations, and less favorable outcome. We evaluated this hypothesis in ophthalmological manifestations (OM) of Behcet's Disease (BD). Visual acuity (VA), anterior uveitis, posterior uveitis (PU), and retinal vasculitis (RV) were checked, according to Ben Ezra, in 1,515 patients with eye lesions. The data at baseline and last visit were compared. Male/female ratio was 1.2 in the BD registry (6,500 patients) and 1.51 for OM patients (Chi2 = 98.962, p < 0.0001). The patients-year-follow-up was 4,987. All parameters improved significantly from the baseline. Mean VA improved from 4.87 to 5.35 for males (p < 0.0001) and from 5.20 to 5.74 for females (p < 0.0001). Difference between males/females at baseline was not significant (p = 0.60). The mean improvement for males/females was statistically non-significant (p = 0.58). Percent improvement of eyes for males/females was 47.1%/48.8% (p = 0.41). Mean PU improved from 1.83 to 0.71 for males (p < 0.0001) and from 1.66 to 0.49 for females (p < 0.0001). Difference between males/females at baseline was significant (p = 0.01). The mean improvement for males/females was statistically non-significant (p = 0.45). Percent improvement of eyes for males/females was 75.4%/81.0% (p = 0.004). Mean RV improved from 2.05 to 1.16 for males (p < 0.0001) and from 1.97 to 0.99 for females (p < 0.0001). Difference between males/females at baseline was not significant (p = 0.42). The mean improvement for males/females was statistically non-significant (p = 0.47). Percent improvement of eyes for males/females was 62%/64.4% (p = 0.33). Male gender is more prone to ocular manifestations. The severity of lesions at baseline was the same for VA and RV. For PU, the difference was statistically significant, but was not clinically relevant. The therapeutic outcome (mean improvement and percent of improved eyes) was the same for all parameters.
Literature
1.
go back to reference Yazici H, Tuzun Y, Pazarli H et al (1984) Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis 43:783–789PubMedCrossRef Yazici H, Tuzun Y, Pazarli H et al (1984) Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis 43:783–789PubMedCrossRef
2.
go back to reference Yazici H, Tüzün Y, Tanman AB et al (1985) Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 3:137–141PubMed Yazici H, Tüzün Y, Tanman AB et al (1985) Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 3:137–141PubMed
3.
go back to reference Dilsen N, Konice M, Aral O, Ocal L, Gul A (1993) Risk factors for vital organ involvement in Behcet's Disease. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 165–169 Dilsen N, Konice M, Aral O, Ocal L, Gul A (1993) Risk factors for vital organ involvement in Behcet's Disease. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 165–169
4.
go back to reference Yazici H, Basaran G, Hamuryudan V et al (1996) The ten year mortality in Behcet's syndrome. Br J Rheumatol 35:139–141PubMedCrossRef Yazici H, Basaran G, Hamuryudan V et al (1996) The ten year mortality in Behcet's syndrome. Br J Rheumatol 35:139–141PubMedCrossRef
5.
go back to reference Muhaya M, Lightman S, Ikeda E et al (2000) Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148PubMed Muhaya M, Lightman S, Ikeda E et al (2000) Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148PubMed
6.
go back to reference Gurler A, Tursen U, Boyvat A (2000) The evaluation of the clinical findings according to age and sex in 2313 Behcet's patients followed up at the multi-disciplinary Behcet's disease Center in Ankara University School of Medicine. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 84–88 Gurler A, Tursen U, Boyvat A (2000) The evaluation of the clinical findings according to age and sex in 2313 Behcet's patients followed up at the multi-disciplinary Behcet's disease Center in Ankara University School of Medicine. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 84–88
7.
go back to reference Madanat W, Fayyad F, Verity D, Zureikat H (2000) Influence of sex on behcet's Disease in Jordan. In: Bang D, Lee E, Lee S (eds) behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93 Madanat W, Fayyad F, Verity D, Zureikat H (2000) Influence of sex on behcet's Disease in Jordan. In: Bang D, Lee E, Lee S (eds) behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93
8.
go back to reference Ames PR, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) 40:652–655CrossRef Ames PR, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) 40:652–655CrossRef
9.
go back to reference Davatchi F, Shahram F, Chams H (2003) The influence of gender on the severity and the outcome of ocular lesions in Behçet's disease. Adv Exp Med Biol 528:67–71PubMedCrossRef Davatchi F, Shahram F, Chams H (2003) The influence of gender on the severity and the outcome of ocular lesions in Behçet's disease. Adv Exp Med Biol 528:67–71PubMedCrossRef
10.
go back to reference Bang D, Oh S, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci 18:231–235PubMed Bang D, Oh S, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci 18:231–235PubMed
11.
go back to reference Janati K, EL Omari K, Benchiki H, Hamdani M, Lakhdar H (2005) Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department). Rev Méd Interne 26:771–776PubMedCrossRef Janati K, EL Omari K, Benchiki H, Hamdani M, Lakhdar H (2005) Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department). Rev Méd Interne 26:771–776PubMedCrossRef
12.
go back to reference Ricart JM, Todolí J, Vilata JJ et al (2006) Behçet disease: study of 74 patients. Med Clin (Barc) 127:496–499CrossRef Ricart JM, Todolí J, Vilata JJ et al (2006) Behçet disease: study of 74 patients. Med Clin (Barc) 127:496–499CrossRef
13.
go back to reference Düzgün N, Ateş A, Aydintuğ OT, Demir O, Olmez U (2006) Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 35:65–68PubMedCrossRef Düzgün N, Ateş A, Aydintuğ OT, Demir O, Olmez U (2006) Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 35:65–68PubMedCrossRef
14.
go back to reference Benamour S, Naji T, Alaoui FZ, El-Kabli H, El-Aidouni S (2006) Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature. Neurol (Paris) 162:1084–1090 Benamour S, Naji T, Alaoui FZ, El-Kabli H, El-Aidouni S (2006) Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature. Neurol (Paris) 162:1084–1090
15.
go back to reference Kwon TW, Park SJ, Kim HK, Yoon HK, Kim GE, Yu B (2008) Surgical treatment result of abdominal aortic aneurysm in Behçet's disease. Eur J Vasc Endovasc Surg 35:173–180PubMedCrossRef Kwon TW, Park SJ, Kim HK, Yoon HK, Kim GE, Yu B (2008) Surgical treatment result of abdominal aortic aneurysm in Behçet's disease. Eur J Vasc Endovasc Surg 35:173–180PubMedCrossRef
16.
go back to reference Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A (2008) Clinical features of chinese patients with Behçet's disease. Ophthalmology 115:312–318PubMedCrossRef Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A (2008) Clinical features of chinese patients with Behçet's disease. Ophthalmology 115:312–318PubMedCrossRef
17.
go back to reference Davatchi F, Sadeghi Abdollahi B, Shahram F et al (2010) Validation of the International Criteria for Behcet's Disease (ICBD) in Iran. Int J Rheum Dis 13:55–60PubMedCrossRef Davatchi F, Sadeghi Abdollahi B, Shahram F et al (2010) Validation of the International Criteria for Behcet's Disease (ICBD) in Iran. Int J Rheum Dis 13:55–60PubMedCrossRef
18.
go back to reference International Team for the Revision of the International Criteria for Behcet's Disease (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 24(Suppl 42):S14–S15 International Team for the Revision of the International Criteria for Behcet's Disease (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 24(Suppl 42):S14–S15
19.
go back to reference Davatchi F, Shams H, Shahram F et al (2005) Management of ocular manifestations of Behcet's Disease: outcome with cytotoxic drugs. APLAR J Rheumatol 8:119–123CrossRef Davatchi F, Shams H, Shahram F et al (2005) Management of ocular manifestations of Behcet's Disease: outcome with cytotoxic drugs. APLAR J Rheumatol 8:119–123CrossRef
20.
go back to reference Davatchi F, Shahram F, Chams-Davatchi C et al (2010) How to deal with Behcet's Disease in daily practice. Int J Rheum Dis 13:105–116PubMedCrossRef Davatchi F, Shahram F, Chams-Davatchi C et al (2010) How to deal with Behcet's Disease in daily practice. Int J Rheum Dis 13:105–116PubMedCrossRef
21.
go back to reference Ben Ezra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P (eds). Uveitis scoring system. Sandoz Ltd and Springer Verlag, Berlin Heidelberg. Ben Ezra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P (eds). Uveitis scoring system. Sandoz Ltd and Springer Verlag, Berlin Heidelberg.
22.
go back to reference Davatchi F, Shams H, Shahram F et al (2009) Longitudinal study of chlorambucil in ocular manifestations of Behcet's Disease. Iranian J Ophthalmol 21:3–14 Davatchi F, Shams H, Shahram F et al (2009) Longitudinal study of chlorambucil in ocular manifestations of Behcet's Disease. Iranian J Ophthalmol 21:3–14
24.
go back to reference Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet's Disease from East to West. Clin Rheumatol 29:823–833PubMedCrossRef Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet's Disease from East to West. Clin Rheumatol 29:823–833PubMedCrossRef
25.
go back to reference Koh (2000) Ophthalmologic manifestation of Behcet's Disease. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93 Koh (2000) Ophthalmologic manifestation of Behcet's Disease. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93
Metadata
Title
Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years
Authors
Fereydoun Davatchi
Farhad Shahram
Hormoz Shams
Abdolhadi Nadji
Cheyda Chams-Davatchi
Massoomeh Akhlaghi
Seyedeh Tahereh Faezi
Farima Ashofteh
Bahar Sadeghi-Abdollahi
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1574-4

Other articles of this Issue 4/2011

Clinical Rheumatology 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.